Viscogliosi Brothers Acquires Stryker's U.S. Spine Business to Create VB Spine

VB Spine Acquires Stryker's Cestas Manufacturing Facility

January 6, 2026

Medical Devices

VB Spine LLC completed the acquisition of Stryker’s spinal implant manufacturing facility in Cestas, France, transferring site employees and operations to VB Spine. The deal expands VB Spine’s global manufacturing footprint and is financed in part by equity investors Viscogliosi Brothers entities with support from Barings.

VB Spine Acquires Stryker’s Spinal Implants Business in Australia and New Zealand

July 31, 2025

Medical Devices

VB Spine LLC has completed the acquisition of Stryker’s spinal implants business in Australia and New Zealand. The deal marks VB Spine’s first market entry outside the United States; LifeHealthcare will remain the exclusive distributor across both countries, and Viscogliosi Brothers LLC and Viscogliosi Brothers Watermark LLC are equity investors in VB Spine.

Stryker Acquires NICO Corporation

September 20, 2024

Medical Devices

Stryker has completed the acquisition of NICO Corporation, a privately held developer of minimally invasive neurosurgical systems including BrainPath and Myriad. The purchase expands Stryker's neurotechnology portfolio and strengthens its capabilities in tumor resection and treatment of intracerebral hemorrhage (stroke) worldwide.

Stryker Acquires Vertos Medical Inc.

August 22, 2024

Medical Devices

Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.

Nevro Corp. Acquires Vyrsa Technologies

November 30, 2023

Medical Devices

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.

Boston Scientific Acquires Vertiflex from H.I.G. BioHealth Partners

June 18, 2019

Medical Devices

Boston Scientific acquired Vertiflex, Inc., a Carlsbad-based developer of the Superion interspinous spacer for lumbar spinal stenosis, for approximately $465 million in cash plus contingent payments. The transaction was announced in May 2019 and completed in June 2019; Vertiflex had been backed by H.I.G. BioHealth Partners.